Intelligent Bio Solutions Inc.

INBS

US36151G6008

Biotechnology & Medical Research

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
2.34 ^USD	-2.09%		-5.26%	-42.29%

May. 08	Earnings Flash (INBS) INTELLIGENT BIO SOLUTIONS Reports Q3 Revenue $823,800	MT
May. 08	Intelligent Bio Solutions Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI

GBS Inc. Announces Resignation of Leon Kempler as Member of the Board

April 29, 2022 at 05:01 pm EDT

On April 27, 2022, Leon Kempler, a member of the Board of Directors of GBS Inc., resigned as a member of the Board effective as of such date.

Latest news about Intelligent Bio Solutions Inc.

Earnings Flash (INBS) INTELLIGENT BIO SOLUTIONS Reports Q3 Revenue $823,800	May. 08	MT
Intelligent Bio Solutions Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	May. 08	CI
Intelligent Bio Solutions Inc. announced that it has received $10.116165 million in funding	Mar. 11	CI
Intelligent Bio Solutions Inc. announced that it expects to receive $10.116165 million in funding	Mar. 07	CI
Top Premarket Decliners	Feb. 12	MT
Top Midday Gainers	Feb. 09	MT
Earnings Flash (INBS) INTELLIGENT BIO SOLUTIONS Reports Q2 Revenue $764,063	Feb. 09	MT
Intelligent Bio Solutions Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 09	CI
Sector Update: Health Care Stocks Advance Late Afternoon	Feb. 02	MT
Sector Update: Health Care Stocks Decline Friday Afternoon	Feb. 02	MT
Top Midday Gainers	Feb. 02	MT
Intelligent Bio Solutions Inc. Provides Unaudited Preliminary Earnings Guidance for the Second Quarter and Six Months Ended December 31, 2023	Feb. 02	CI
Sector Update: Health Care Stocks Stronger Late Afternoon	Jan. 29	MT
Sector Update: Health Care	Jan. 29	MT
Intelligent Bio Solutions Says Fingerprinting Drug Screening System Being Used by UK Timber Processor; Shares Soar	Jan. 29	MT
James Jones & Sons Ltd. Adopts Intelligent Bio Solutions Inc.'s Fingerprint Drug Screening System Across its 25 Sites and 1,300 Employees	Jan. 29	CI
Intelligent Bio Solutions Inc. Announces Selection of the Revolutionary Portable Intelligent Fingerprinting Drug Screening System by Dgp plc	Jan. 22	CI
Intelligent Bio Solutions Receives NATA Accreditation for Its Revolutionary Fingerprint Sweat Drug Screening System	Dec. 19	CI
P&O Ferries, Adopts Fingerprint Drug Screening Solution for On-Board, Random Testing of Seafaring Staff	Dec. 05	CI
Intelligent Bio Solutions Inc. Announces Titan Cranes and Rigging Pty Ltd. Adopts Intelligent Fingerprinting Drug Screening System	Nov. 30	CI
Intelligent Bio Solutions to Provide Fingerprinting Drug Screening System to Australian Firm; Shares Rise	Nov. 27	MT
Wall Street Set to Open Slightly Higher as Investors Parse Powell Remarks	Nov. 10	MT
Top Premarket Gainers	Nov. 10	MT
Sector Update: Health Care Stocks Falling Late Afternoon	Nov. 09	MT
Top Midday Gainers	Nov. 09	MT

Chart Intelligent Bio Solutions Inc.

Duration

Period

More charts

Intelligent Bio Solutions Inc. is a life sciences company. The Company is engaged in developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It operates through two segments, namely Commercially available Intelligent Fingerprinting Products (IFPG) and Development Stage Saliva Glucose Biosensor Platform (SGBP). Its product portfolio includes a portable drug screening system that works by analyzing fingerprint sweat using a one-time cartridge and portable handheld reader and also includes a development stage range of biosensor- based Point of Care diagnostic tests (POCT) that are developed in the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology. Its product candidate is the Saliva Glucose Biosensor (SGB), a POCT expected to substitute the finger pricking invasive blood glucose monitoring for diabetic patients. Its Biosensor Platform helps to detect multiple biological analytes.

Sector

Biotechnology & Medical Research

Calendar

2024-11-05 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Intelligent Bio Solutions Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.25 USD

Average target price

42 USD

Spread / Average Target

+1,766.67%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
INTELLIGENT BIO SOLUTIONS INC.	-42.29%	6.77M
EXACT SCIENCES CORPORATION	-31.90%	9.59B
GUARDANT HEALTH, INC.	-6.25%	3.21B
IOVANCE BIOTHERAPEUTICS, INC.	+25.95%	2.92B
BGI GENOMICS CO., LTD.	-13.96%	2.15B
VERACYTE, INC.	-16.83%	1.79B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+72.82%	1.47B
CAREDX, INC	+29.17%	770M
SEEGENE, INC.	-2.62%	761M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-26.33%	548M

Bio Diagnostics & Testing

Intelligent Bio Solutions Inc.

Equities

INBS

US36151G6008

Biotechnology & Medical Research

GBS Inc. Announces Resignation of Leon Kempler as Member of the Board

Latest news about Intelligent Bio Solutions Inc.

Chart Intelligent Bio Solutions Inc.

Company Profile

Income Statement Evolution

Ratings for Intelligent Bio Solutions Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Bio Diagnostics & Testing